source
- Eli Lilly's obesity drugs Foundayo and Zepbound added to CVS Caremark formularyEli Lilly announced that its two flagship obesity treatments, the oral agent Foundayo and the injectable Zepbound, will be listed on CVS Caremark's drug formularies. The inclusion comes as the GLP…
- AbbVie receives FDA approval for ultra-rare blood cancer ADC acquired from ImmunoGenAbbVie announced that the U.S. Food and Drug Administration has granted approval for an antibody-drug conjugate targeting an ultra-rare, aggressive form of blood cancer. The therapy was obtained t…